Jan 17, 2024, 08:41 AM by

Discovery Park Ventures (DPV) announces an investment of £100K into Vox Imaging Technology Ltd. (VIT), an ambitious ophthalmic technology company looking to transform eye imaging in preclinical research and improve drug discovery and development. Its compact and customisable instrument is believed to be the first scanning laser ophthalmoscope especially designed for laboratory use, able to produce high-quality data rapidly. Vox Imaging is the eighth investment from DPV’s first fund.

Jan 17, 2024, 08:41 AM by

Biopharma PEG, a leading provider of polyethylene glycol (PEG) derivatives, is proud to introduce an extended Azide PEG series that includes monodispersed, polydispersed, and multi-arm PEGs.

Jan 17, 2024, 08:41 AM by

Qlucore has signed an agreement with Sahlgrenska Hospital in Gothenburg, Sweden. The hospital will use the Qlucore Insights software to improve the diagnosis of acute lymphoblastic leukemia (ALL) in children.

Jan 17, 2024, 08:41 AM by

Chong Toh Ying has more than 16 years’ experience managing large datasets and building and leading software engineering teams that deliver fast and accurate results.

Jan 17, 2024, 01:00 AM by User Not Found

Bio-IT World | At this year’s JP Morgan Healthcare conference, biotech and diagnostic companies and experts provided overviews of 2023 accomplishments and their goals for 2024. We’ve covered presentations by NVIDIA, Regeneron, Illumina, Pacific Biosciences, and Oxford Nanopore in depth. Here we list highlights from Pfizer, Moderna, Eli Lilly, Thermo Fisher, and more.

Jan 16, 2024, 08:59 AM by

Jan 16, 2024, 08:59 AM by

Andelyn Biosciences and Armatus Bio are partnering to accelerate the manufacturing of a suspension-based AAV gene therapy for Charcot-Marie-Tooth Type 1A (CMT1A), a rare neurological disease. The collaboration aims to maximize program efficiency and speed up clinical studies using Andelyn's expertise in AAV production and suspension platform. The initiative brings hope to patients with unmet needs in neuromuscular diseases.

Jan 16, 2024, 08:59 AM by

Jan 16, 2024, 01:00 AM by User Not Found

Bio-IT World | CEO Gordan Sanghera gave Oxford Nanopore’s first live presentation at the JP Morgan Healthcare Conference last week. He highlighted his platforms accuracy and the company’s consumable growth.

Jan 12, 2024, 08:02 AM by

Leading bioinformatics software company Qlucore has agreed a two-year license with the large pharmaceutical company Boehringer Ingelheim worth approximately 1.67 million SEK.

Jan 12, 2024, 01:00 AM by User Not Found

Bio-IT World | Christian Henry, President and CEO of Pacific Biosciences, was unabashedly cheerful at the JP Morgan Healthcare Conference on Wednesday afternoon when he gave the updates for PacBio. “2023 absolutely exceeded our expectations,” he said, basking in two platform launches, strong consumable growth, and three new platforms in development.

Jan 10, 2024, 08:46 AM by

EMTELLIGENT'S EMTELLIPRO MEDICAL AI PLATFORM NAMED ONE OF THE MOST INTERESTING INNOVATIONS OF 2023 BY PM360

Jan 10, 2024, 08:46 AM by

PubHive elevates local literature workflow: Unprecedented Automation for Online and Paper Journals Enhances Global Pharmacovigilance Efficiency.

Jan 10, 2024, 01:00 AM by User Not Found

Bio-IT World | CEO Jacob Thaysen presented Illumina’s updates yesterday at the JP Morgan Healthcare Conference. 2023 has been an eventful year for the sequencing pioneer with December’s announcement that Illumina would divest GRAIL; Francis deSouza, Illumina’s former CEO, stepping down in June; and $175M in cost cuts over the course of 2023 which included headcount reductions and major real estate changes. Thaysen presented Illumina at a turning point.

Jan 9, 2024, 06:26 AM by

I wanted to reach out with the latest news from Verdot, who have recently forged a strategic partnership with Bio-Link, a prominent Chinese bioprocessing company. The collaboration aims to advance biopharmaceutical manufacturing in China, with Bio-Link becoming the major distributor for Verdot’s innovative chromatography columns in the Chinese market The full release and images are below. Thank you Charlotte

Jan 9, 2024, 01:00 AM by User Not Found

Bio-IT World | Chris Gibson, CEO of Recursion, launched a live demo of Recursion’s new large language model orchestration work engine, LOWE, yesterday at the JP Morgan Healthcare Conference. The tool is the next step toward Recursion’s goal of autonomous drug discovery.

Jan 8, 2024, 17:04 PM by User Not Found

Bio-IT World | Drug design is at a tipping point, Kimberly Powell, vice president of Healthcare for NVIDIA, argued in her Monday morning presentation at the JP Morgan Healthcare Conference. “Two necessary conditions have arrived for drugs: digitizing biology and being able to represent it in a computer. We have the perfect conditions to see a massive expansion of this computer-aided drug discovery industry,” she said. And generative AI is the class of tools that will facilitate it.

Jan 8, 2024, 08:12 AM by

Jan 8, 2024, 08:12 AM by

Jan 8, 2024, 08:12 AM by